Cargando…

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor?Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors

PURPOSE: Although combining aromatase inhibitors (AI) with gonadotropin-releasing hormone agonists (GnRHa) is becoming more common, it is still not clear if GnRHa is as effective as bilateral salpingo-oophorectomy (BSO). MATERIALS AND METHODS: We retrospectively analyzed data of 66 premenopausal pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suh, Koung Jin, Kim, Se Hyun, Lee, Kyung-Hun, Kim, Tae-Yong, Kim, Yu Jung, Han, Sae-Won, Kang, Eunyoung, Kim, Eun-Kyu, Kim, Kidong, No, Jae Hong, Han, Wonshik, Noh, Dong-Young, Lee, Maria, Kim, Hee Seung, Im, Seock-Ah, Kim, Jee Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654164/ https://www.ncbi.nlm.nih.gov/pubmed/28253566 http://dx.doi.org/10.4143/crt.2016.463

Ejemplares similares

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
por: Johansen, Nora, et al.
Publicado: (2018)

Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer
por: Shin, Jae Jun, et al.
Publicado: (2020)

Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
por: Lee, June Koo, et al.
Publicado: (2013)

Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause
por: Manchanda, R, et al.
Publicado: (2022)

Laparoscopic Salpingo-oophorectomy in Conscious Sedation
por: Rosati, Maurizio, et al.
Publicado: (2015)

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea
por: Beom, Seung Hoon, et al.
Publicado: (2017)

Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients
por: Kim, Hee Jeong, et al.
Publicado: (2015)

Comparison of outcomes in patients with luminal type breast cancer treated with a gonadotropin-releasing hormone analog or bilateral salpingo-oophorectomy: A cohort retrospective study
por: Andriyanto, Dwi Ris, et al.
Publicado: (2022)

Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea
por: Park, Boyoung, et al.
Publicado: (2022)

Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy
por: Kessler, Alaina J., et al.
Publicado: (2023)

Prophylactic oophorectomy and aromatase inhibitors for premenopausal deep angiomyxoma: A case report and literature review
por: Tonai, Nobutomo, et al.
Publicado: (2022)

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
por: Gaba, Faiza, et al.
Publicado: (2022)

Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study
por: Lim, Hyunji, et al.
Publicado: (2021)

Effects of human growth hormone on gonadotropin-releasing hormone neurons in mice
por: Bhattarai, Janardhan P., et al.
Publicado: (2010)

Predictive Value of Dental Maturity for a Positive Gonadotropin-Releasing Hormone Stimulation Test Result in Girls with Precocious Puberty
por: Baik, Jee-Seon, et al.
Publicado: (2017)

Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer
por: Lee, Soohyeon, et al.
Publicado: (2022)

The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review
por: Siyam, Tasneem, et al.
Publicado: (2017)

Bone density loss after risk reducing salpingo-oophorectomy
por: Andrews, L, et al.
Publicado: (2012)

Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy
por: Chen, Hao, et al.
Publicado: (2016)

Analysis of Prophylactic Salpingo-oophorectomy at the Time of Hysterectomy for Benign Lesions
por: Jain, Sheela Hemant, et al.
Publicado: (2019)

Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy
por: Hidari, Tokie, et al.
Publicado: (2019)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Transvaginal laparoscopic salpingo-oophorectomy: an oncological risk-reducing procedure
por: Lathouras, Kostas, et al.
Publicado: (2019)

Bilateral Salpingo-Oophorectomy for Intracardiac Leiomyomatosis: A Case Report
por: Liang, Jinxiao, et al.
Publicado: (2022)

Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers
por: Riggs, McKayla J., et al.
Publicado: (2020)

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011)

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
por: Yoon, Jong Wan, et al.
Publicado: (2017)

The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress
por: Kim, Hyun-Ah, et al.
Publicado: (2016)

Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)
por: Lee, Soohyeon, et al.
Publicado: (2020)

Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

The Effect of Combined Growth Hormone and a Gonadotropin-Releasing Hormone Agonist Therapy on Height in Korean 3-M Syndrome Siblings
por: Lee, In Kyung, et al.
Publicado: (2020)

Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review
por: Park, Sun-young, et al.
Publicado: (2020)

Cessation of Gonadotropin-Releasing Hormone Antagonist on Triggering Day: An Alternative Method for Flexible Multiple-Dose Protocol
por: Chang, Hye Jin, et al.
Publicado: (2009)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
por: Jung, Mo Kyung, et al.
Publicado: (2014)

Effect of Estrogen Receptor Expression Level and Hormonal Therapy on Prognosis of Early Breast Cancer
por: Yoon, Kyung-Hwak, et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
por: Choi, Hee Jun, et al.
Publicado: (2023)

Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
por: Lee, Young-Jae, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5h3v7tff3rcrev8el617tj3p5m